Target intelligence / Profile preview

CALHM2 antisense RNA 1 (CALHM2-AS1)

Target
CALHM2-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

CALHM2 antisense RNA 1 (CALHM2-AS1) is a long non-coding RNA transcribed from the DNA strand opposite to the protein-coding gene CALHM2. Antisense RNAs in general function by modulating the expression of their sense partner genes through mechanisms such as interference with transcription, promoting or repressing gene expression via chromatin remodeling, or direct mRNA hybridization. No direct experimental data exists regarding the biological role, disease association, or druggability of CALHM2-AS1. The sense gene, CALHM2, encodes a large pore ion channel involved in ATP release and glial signaling, with emerging relevance in neurobiology. CALHM2-AS1 may regulate CALHM2 expression, but as of the current knowledge, its specific functions and disease connections remain uncharacterized.

02

Mechanism of action

Not applicable (no drugs or experimental agents documented to directly target this transcript)

03

Biological functions

Regulation of gene expression (by antisense transcript mechanisms, such as modulation of CALHM2 transcription or chromatin state)
04

Disease associations

Other

Beyond the preview

Go deeper on CALHM2 antisense RNA 1 (CALHM2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CALHM2 antisense RNA 1 (CALHM2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call